Prevalence and characteristics of the metabolically healthy obese phenotype in children and adolescents in a Mexican state.
Adolescentes
Adolescents
Children
Cociente triglicéridos/HDL
HOMA-IR
Insulin resistance
Metabolically Obese Normal-Weight
Metabolically healthy obese
Metabólicamente obeso con peso normal
Niños
Obeso metabólicamente sano
Resistencia a la insulina
Triglycerides/HDL ratio
Journal
Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
09
08
2019
revised:
17
03
2020
accepted:
25
03
2020
pubmed:
15
10
2020
medline:
15
10
2020
entrez:
14
10
2020
Statut:
ppublish
Résumé
To determine the prevalence of the Metabolically Healthy Obesity (MHO), and Metabolically Obese Normal-Weight (MONW) phenotypes in a sample of children and adolescents. To evaluate which clinical and laboratory variables are related to the MONW and MHO phenotypes. A cross-sectional study was carried out in children and adolescents aged 6-18 years old, presumably healthy. Somatometry, glucose, insulin, triglycerides, HDL-cholesterol, LDL-cholesterol, HOMA-IR, triglycerides/HDL ratio, triglycerides and glucose index, and leptin/adiponectin, were determined. Data from 620 children and adolescents were included (50.65% were males); the median age was 11 years. The prevalence of the MONW phenotype was 22.85% (95%CI 16.85%-29.79%), and the MHO phenotype 27.61% (95%CI 22.60%-33.06%). The variables that significantly explained the possibility of presenting the MONW and MHO phenotype were triglycerides/HDL ratio, and product of triglycerides and glucose. Insulin and HOMA-IR were significantly associated with the MHO phenotype but not with the MONW phenotype. Prevalence of metabolically healthy obese phenotype is lower in the Mexican population compared to European studies; thus, future studies should determine if this difference relies upon genetic profile or lifestyle. The indices to assess the action of insulin based on lipids can help identify children and adolescents with the MHO and MONW phenotypes.
Identifiants
pubmed: 33051160
pii: S2530-0164(20)30160-9
doi: 10.1016/j.endinu.2020.03.015
pii:
doi:
Types de publication
Journal Article
Langues
eng
spa
Sous-ensembles de citation
IM
Pagination
625-635Informations de copyright
Copyright © 2020. Publicado por Elsevier España, S.L.U.